What Is Compounded GLP-1? Everything Patients Need to Know
A clear, patient-friendly explanation of compounded semaglutide and tirzepatide -- what they are, how they work, and whether they are right for you.
If you have been researching semaglutide or tirzepatide for weight loss, you have probably come across the term "compounded GLP-1." These medications have made GLP-1 therapy accessible to millions of patients who cannot afford or access brand-name options. Here is everything you need to understand.
What Is Compounding?
Compounding is the practice of creating customized medications tailored to a patient's needs. Licensed compounding pharmacies combine pharmaceutical-grade ingredients to produce medications based on a doctor's prescription. Compounding has been part of pharmacy practice for centuries and is regulated by both state pharmacy boards and the FDA.
There are two types of compounding pharmacies relevant to GLP-1 medications:
503A Pharmacies
- Type: Traditional compounding pharmacies
- Scale: Individual patient prescriptions
- Regulation: State pharmacy board oversight
- Prescriptions: Must have patient-specific Rx
- Best for: Customized dosing needs
503B Outsourcing Facilities
- Type: FDA-registered facilities
- Scale: Larger batch production
- Regulation: FDA inspection and cGMP standards
- Prescriptions: Can produce without patient-specific Rx
- Best for: Broader distribution and consistency
What Is Compounded GLP-1 Specifically?
Compounded GLP-1 refers to semaglutide or tirzepatide that is prepared by a compounding pharmacy rather than manufactured by Novo Nordisk (Wegovy/Ozempic) or Eli Lilly (Mounjaro/Zepbound). The active ingredient is the same, but the finished product is compounded from bulk pharmaceutical-grade ingredients.
Key Facts About Compounded GLP-1
- Same active ingredient as brand-name medications
- Requires a prescription from a licensed provider
- Legal during FDA-recognized shortages of the brand product
- Significantly more affordable than brand-name versions
- Available in multiple forms including injectable and sublingual
Legal Status of Compounded GLP-1
The legality of compounded GLP-1 medications centers on FDA drug shortage designations. Under the Federal Food, Drug, and Cosmetic Act (specifically Section 503A and 503B), compounding pharmacies may produce copies of FDA-approved drugs when those drugs are on the FDA's drug shortage list.
As of early 2026, both semaglutide and tirzepatide have experienced supply constraints. However, the regulatory landscape is evolving. Patients should stay informed about current shortage status and work with reputable providers who maintain compliance with all applicable regulations.
Brand-Name vs. Compounded: Key Differences
| Feature | Brand-Name | Compounded |
|---|---|---|
| Active ingredient | Semaglutide or tirzepatide | Same active ingredient |
| FDA approval | Fully FDA-approved | Not individually approved; pharmacy is FDA-registered |
| Monthly cost | $1,000-1,400 | $200-600 |
| Delivery device | Pre-filled auto-injector pen | Vial with syringes or sublingual |
| Dose customization | Fixed dose strengths | Flexible dosing available |
| Insurance coverage | Sometimes covered | Rarely covered by insurance |
How to Get Compounded GLP-1
Accessing compounded GLP-1 medications involves a few straightforward steps:
- Medical evaluation: Consult with a licensed healthcare provider (in-person or via telehealth) who can assess your eligibility for GLP-1 therapy.
- Prescription: If appropriate, your provider writes a prescription for compounded semaglutide or tirzepatide.
- Pharmacy selection: Your prescription is sent to a verified compounding pharmacy (503A or 503B).
- Delivery: Medication is shipped directly to you, typically with cold-chain packaging.
- Ongoing care: Regular follow-ups with your provider for dose adjustments and monitoring.
Safety Considerations
Important Safety Information
- • Always verify your compounding pharmacy's credentials and licensing
- • Ensure the pharmacy uses USP-grade active pharmaceutical ingredients
- • Confirm third-party potency and sterility testing is performed
- • Watch for red flags such as no prescription requirement or unusually low pricing
- • Report any adverse effects to your healthcare provider immediately
- • Store medication according to pharmacy instructions (typically refrigerated)
Who Should Consider Compounded GLP-1?
Compounded GLP-1 may be a good option if you:
- Cannot afford brand-name Wegovy or Zepbound ($1,000+ per month)
- Do not have insurance coverage for weight loss medications
- Have been denied insurance coverage or prior authorization
- Need a customized dose not available in brand-name products
- Prefer sublingual delivery over injections (some compounders offer this)
Compounded GLP-1 may not be appropriate if you have a preference for FDA-approved finished products, if your insurance fully covers brand-name options, or if you have specific medical conditions that require the exact formulation used in clinical trials.
The Bottom Line
Compounded GLP-1 medications have opened the door to effective weight loss therapy for millions of patients who would otherwise be priced out. When sourced from legitimate, licensed compounding pharmacies, they offer a safe and affordable alternative to brand-name options. The key is doing your due diligence: verify pharmacy credentials, ensure proper testing is performed, and always work with a licensed healthcare provider.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved finished products. Always consult with a qualified healthcare provider before starting any medication. Individual results may vary.
Explore Affordable GLP-1 Options
Get access to physician-prescribed compounded GLP-1 medications with full medical support.
Get Started TodayMore on compounding education
How Compounding Pharmacies Make GLP-1
The manufacturing process behind compounded semaglutide and tirzepatide
What's in Compounded GLP-1?
Full ingredient breakdown of compounded medications
Compounding Red Flags
How to spot unsafe compounding providers
Compounded Semaglutide Safety
Safety profile of compounded semaglutide
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).